Latest Compression fracture Stories
SANTA CLARA, Calif., July 19, 2011 /PRNewswire/ -- Benvenue Medical, Inc., a developer of minimally invasive solutions for spine repair, announced the addition of two key members of the senior management team with deep sales and marketing experience that will lead product commercialization efforts in the US and Europe.
SAN JOSE, Calif. and TAMPA, Fla., June 6, 2011 /PRNewswire/ -- DFINE, Inc., the developer of minimally invasive radio frequency (RF) targeted therapies for the treatment of vertebral pathologies, announced today that H.
ATLANTA, May 24, 2011 /PRNewswire/ -- Carol Donald is a vibrant, active 63-year-old woman who has been living with osteoporosis for over 10 years. With her bone density compromised, Carol suffered from a fracture in her spine when she was involved in a car accident earlier this year.
SAN JOSE, Calif., May 24, 2011 /PRNewswire/ -- DFINE, Inc., the developer of minimally invasive radio frequency (RF) targeted therapies for the treatment of vertebral pathologies, today announced two new product enhancements to its StabiliTÂ® Vertebral Augmentation System - the most advanced treatment option for vertebral compression fractures (VCFs). Designed to improve the physician experience and provide greater flexibility and ease-of-use for the minimally invasive treatment of VCFs,...
One in 10 heart failure patients had compression fractures in the spine that could have been detected by a chest X-ray, but few are receiving treatment to help prevent such fractures.
SANTA CLARA, Calif., April 18, 2011 /PRNewswire/ -- Benvenue Medical, Inc., a developer of minimally invasive solutions for spine repair, announced the completion of a $35.5 million Series C round of financing.
SANTA ROSA, Calif., March 29, 2011 /PRNewswire/ -- OsseonÂ® Therapeutics announced today at the Society of Interventional Radiology's (SIR) Annual Meeting the launch of the Osseoflex BT Steerable Bone Tamp. The steerable bone tamp is designed to allow percutaneous access to sclerotic bone.
THOUSAND OAKS, Calif., March 23, 2011 /PRNewswire/ -- Amgen (Nasdaq: AMGN) today announced new data that showed postmenopausal women with osteoporosis had significantly greater adherence, compliance, and persistence during ProliaÂ® (denosumab) treatment than during alendronate treatment, an oral bisphosphonate commonly used to treat osteoporosis.
DAYTON, Ohio, Nov. 29, 2010 /PRNewswire/ -- Results of a large-scale study, "Vertebroplasty vs.
In the news release, AAOS Clinical Guideline for Treating Spinal Compression Fractures Presents More Questions Than Answers for Medical Community, issued 09-Nov-2010 by Wayne J. Olan over PR Newswire, we are advised by the company that there were several updates made to the release.
- Growing in low tufty patches.